Brief: Recursion Pharmaceuticals Announces Personnel And Infrastructure Reduction - SEC Filing
10/06/2025 11:18
June 10 (Reuters) - Recursion Pharmaceuticals Inc RXRX.O: RECURSION PHARMACEUTICALS INC - ANNOUNCES PERSONNEL AND INFRASTRUCTURE REDUCTION - SEC FILING RECURSION PHARMACEUTICALS INC - WORKFORCE REDUCTION EXPECTED TO BE ABOUT 20% - SEC FILING RECURSION PHARMACEUTICALS INC - PROJECTED CASH RUNWAY EXPECTED TO EXTEND INTO Q4 2027 - SEC FILING Source text: [ID:n0001193125-25-138138] Further company coverage: RXRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Recursion Pharmaceuticals
See all newsBrief: Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model
Brief: Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 - SEC Filing
Recursion Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Recursion Pharmaceuticals Q2 revenue misses estimates, cuts 2026 expense outlook
Brief: Recursion Pharmaceuticals Q2 Operating Revenue USD 7.303 Million Vs. IBES Estimate USD 11.9 Million